Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ALLOT LTD (ALLT)

  • Business News
  • Aug. 12, 2026, 10:30 UTC
  • 0
  • 1 comments

Allot Announces Second Quarter 2026 Financial Results

Market reaction Comment Full text

BIO-TECHNE CORP (TECH)

  • Business News
  • Aug. 12, 2026, 10:30 UTC
  • 0
  • 1 comments

Bio-Techne Releases Fourth Quarter Fiscal 2026 Results

Market reaction Comment Full text

VALENS SEMICONDUCTOR LTD. (VLN)

  • Business News
  • Aug. 12, 2026, 10:30 UTC
  • 0
  • 1 comments

Valens Semiconductor Reports Strong Second Quarter 2026 Results and Raises Full-Year Revenue Guidance

Market reaction Comment Full text

PRUDENTIAL PLC (K6S)

  • Business News
  • Aug. 12, 2026, 10:30 UTC
  • 0
  • 1 comments

General Announcement: Next Day Disclosure Return

Market reaction Comment Full text

LIQUIDIA CORP (LQDA)

  • Business News
  • Aug. 12, 2026, 10:30 UTC
  • 0
  • 1 comments

Liquidia Corporation Reports Second Quarter 2026 Financial Results

Market reaction Comment Full text

ITURAN LOCATION & CONTROL LTD. (ITRN)

  • Business News
  • Aug. 12, 2026, 10:30 UTC
  • 0
  • 1 comments

ITURAN PRESENTS SECOND QUARTER 2026 RESULTS

Market reaction Comment Full text

LOCKHEED MARTIN CORP (LMT)

  • Business News
  • Aug. 12, 2026, 10:30 UTC
  • 0
  • 1 comments

Lockheed Martin, Verizon, Keysight, ODC and Astris AI Demonstrate Technology for Public Airspace Protection with NVIDIA Technology

Market reaction Comment Full text

BIO-TECHNE CORP (TECH)

  • Business News
  • Aug. 12, 2026, 10:30 UTC
  • 0
  • 1 comments

Bio-Techne Declares Dividend

Market reaction Comment Full text

VIAVI SOLUTIONS INC. (VIAV)

  • Business News
  • Aug. 12, 2026, 10:30 UTC
  • 1
  • 1 comments

VIAVI Introduces Industrys First Channel Emulator for 6G and Wi-Fi 7/8

Market reaction Comment Full text

ANNICA HOLDINGS LIMITED (JFQ)

  • Business News
  • Aug. 12, 2026, 10:29 UTC
  • 1
  • 1 comments

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Changes in Interest of Director - Lim In Chong

Market reaction Comment Full text
  • Previous
  • 1074
  • 1075
  • 1076
  • 1077
  • 1078
  • Next

Search

News categories

  • Technical Exchange News(14604)
  • Event(6229)
  • SEC News(385338)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(235182)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin